Skip to main content
SpringerLink
Log in

Nitric Oxide (NO) and Obstructive Sleep Apnea (OSA)

  • Review Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Nitric oxide (NO) and obstructive sleep apnea are inseparable. Obstructive sleep apnea could be described as the intermittent failure to transport the full complement of nasal NO to the lung with each breath. There NO matches perfusion to ventilation. NO is utilized by the efferent pathways that control the unequal, inspiratory battle between the pharyngeal dilators and the closing negative pressures induced by the thoracic musculature. Recurrent cortical arousals are a major short-term complication, and the return to sleep after each arousal uses NO. The long-term complications, namely hypertension, myocardial infarction, and stroke, might be due to the repeated temporary dearth of NO in the tissues, secondary to a lack of oxygen, one of NO’s two essential substrates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kula S, RemmersJE. Anatomy and physiology of upper airway obstruction. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia, PA: WB Saunders; 2000:840–858

    Google Scholar 

  2. Krueger JM, Obal Jr F, Fang J, Kubota T, Taishi P. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci 2001;933:211–221

    Google Scholar 

  3. Djupesland PG, Chatkin JM, Qian W, HaightJSJ. Nitric oxide in the nasal airway: a new dimension to otorhinolaryngology. Am J Otolaryngol Head Neck Surg 2002;22:19–32

    Google Scholar 

  4. Antonin I, Mayo,JC, Sainz RM, et al. Protective effect of melatonin in a chronic experimental model of Parkinson’s disease. Brain Res 2002;943:163–173

    Google Scholar 

  5. Cespuglio R, Burlet S, Faradji-Prevautel H. 5-Hydroxy indole compounds and nitric oxide volumetric detection in the rat brain: changes occurring throughout the sleep-wake cycle. J Neural Transm 1998;105(2–3):205–215

    Google Scholar 

  6. Pokk P, Vali M. The effect of the nitric oxide synthase inhibitors on the behaviour of the small-platform-stressed mice in the plus-maze test. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:241–247

    Google Scholar 

  7. Qian W, DjupeslandPG, Haight JSJ. Unpublished data: 2000

  8. Osanai S, Ide H, Yamamoto Y, Nakano H, Kikuchi K. Nitric oxide in sleep apneics Japanese. J Clin Med 2000;58:1665–1670

    Google Scholar 

  9. Agusti AG, Barbe F, Togores B. Exhaled nitric oxide in patients with sleep apnea. Sleep 1999;22:231–235

    Google Scholar 

  10. Haight JSJ, Djupesland PG, Qian W, et al. Does nasal nitric oxide come from the sinuses?. J Otolaryngol 1999;28:197–204

    Google Scholar 

  11. Stamler JS, Loh E, RoddyMA, et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994;89:2035–2040

    Google Scholar 

  12. Blitzer ML, Loh E, RoddyMA, et al. Endothelium derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol 1996;28:591–596

    Article  CAS  PubMed  Google Scholar 

  13. Lundberg JO, Settergren G, Gelinder S, Lundberg JM, AlvingK, Weitzberg E. Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta Physiol Scand 1996;158:343–347

    Google Scholar 

  14. Djupesland PG, Chatkin JM, Qian W, et al. Aerodynamic influences on nasal nitric oxide output measurements. Acta Otolaryngol 1999;119:479–485

    Google Scholar 

  15. Cole P. Stability of nasal airflow resistance. Clin Otolaryngol Allied Sci 1989;14:177–182

    Google Scholar 

  16. Cole P, HaightJSJ. Posture and the nasal cycle. Ann Otol Rhinol Laryngol 1986;95:233–234

    Google Scholar 

  17. Cole P, HaightJSJ. Posture and nasal patency. Am Rev Respir Dis 1984;129:351–354

    Google Scholar 

  18. Haight JSJ, Cole P. Topographic anatomy of the pressure points that alter nasal resistance. J Otolaryngol 1986;15(suppl 16):S14–S14

    Google Scholar 

  19. Qian W, Sabo R, Ohm M, Haight JSJ, FentonR. Nasal nitric oxide and the nasal cycle. Laryngoscope 2001;111:1603–1607

    Google Scholar 

  20. McNicholas WT, Tarlo S, Cole P. Obstructive sleep apnea during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982;126:625–628

    Google Scholar 

  21. Leznoff A, Haight JSJ, HoffsteinV. Reversible obstructive sleep apnea due to occupational exposure to guar gum dust. Am Rev Respir Dis 1986;133:935–936

    Google Scholar 

  22. Djupesland PG, Skatvedt O, BorgersenAK. Dichotomous physiological effects of nocturnal external nasal dilation in heavy snorers: the answer to a rhinologic controversy?. Am J Rhinol 2001;15:95–103

    Google Scholar 

  23. Miljeteig H, Savard P, Mateika S, Cole P, Haight JSJ, HoffsteinV. Snoring and nasal resistance during sleep. Laryngoscope 1993;103:918–923

    Google Scholar 

  24. Cannon 3rdRO, Schechter AN, Panza JA, et al. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 2001;108:279–287

    Google Scholar 

  25. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, ZapolWM. Inhaled nitric oxide for adult respiratory distress syndrome [comment]. N Engl J Med 1993;328:399–405

    Article  CAS  PubMed  Google Scholar 

  26. Klinger JR. Inhaled nitric oxide in ARDS. Crit Care Clin 2002;18:45–68

    Google Scholar 

  27. Singh S, EvansTW. Nitric oxide the biological mediator of the decade: fact or fiction?. Euro Respir J 1997;10:699–707

    Google Scholar 

  28. Jia L, Bonaventura C, Bonaventura J, StamlerJS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996;380:221–226

    Article  CAS  PubMed  Google Scholar 

  29. Stamler JS, Jia L, EuJP, et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 1999;276:2034–2037

    Google Scholar 

  30. Rassaf T, Preik M, Kleinbongard P, et al. Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest 2002;109:1241–1248

    Google Scholar 

  31. Myers JL, Wizorek JJ, Myers AK, et al. Maturation alters the pulmonary arterial response to hypoxia and inhaled nitric oxide in the presence of endothelial dysfunction. J Thorac Cardiovasc Surg 1997;113:270–277

    Google Scholar 

  32. Kobzik L, ReidMB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature 1994;372:546–548

    CAS  PubMed  Google Scholar 

  33. Murrant CL, Woodley NE, Barclay JK. Effect of nitroprusside and endothelium derived products on slow-twitch skeletal muscle function in vitro. Can J Physiol Pharmacol 1994;72:1089–1093

    Google Scholar 

  34. Morrison RJ, Miller IIICC, Reid MB. Nitric oxide effects on shortening velocity and power production in the rat diaphragm. J Appl Physiol 1996;80:1065–1069

    Google Scholar 

  35. Morrison RJ, Miller IIICC, Reid MB. Nitric oxide effects on force-velocity characteristics of the rat diaphragm. Comp Biochem Physiol 1998;119:203–209

    Google Scholar 

  36. Gath I, Closs EI, Godtel-ArmbrustU, et al. Expressed in different structures of guinea-pig skeletal muscle: implications for contractile function. FASEB J 1996;10:1614–1620

    Google Scholar 

  37. Reid MB. Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance. Acta Physiol Scand 1998;162:401–409

    Google Scholar 

  38. Marshall JM. Roles of adenosine and nitric oxide in skeletal muscle in acute and chronic hypoxia. Adv Exp Med Biol 2001;502:349–363

    Google Scholar 

  39. Fitts RH, Balog EM. Effect of intracellular and extracellular ion changes on E-C coupling and skeletal muscle fatigue. Acta Physiol Scand 1996;156:169–181

    Google Scholar 

  40. Bruton JD, Lannergren J, Westerblad H. Mechanisms underlying the slow recovery of force after fatigue: importance of intracellular calcium. Acta Physiol Scand 1998;162:285–293

    Google Scholar 

  41. Gutierrez C, Qian W, Kendall C, Zamel N, Jenkins D, HaightJSJ. Effect of dietary arginine on exhaled and nasal nitric oxide. Am J Respir Crit Care Med 2000;161:A744–A744

    Google Scholar 

  42. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 2001;64:365–391

    Google Scholar 

  43. Blanchard AR, Chaudhary BA. Neuropharmacology of sleep and wakefulness. In: Lee-Chiong TL, Sateira MJ, Carskadon MA eds. Sleep Medicine. Philadelphia, PA; Hanley & Belfus Inc;; 2002:565–574

    Google Scholar 

  44. Leonard TO, Lydic R. Pontine nitric oxide modulates acetylcholine release rapid eye movement sleep generation and respiratory rate. J Neurosci 1997;17:774–785

    Google Scholar 

  45. Seigel JM. Brainstem mechanisms generating REM sleep. In: Kryger M, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia, PA: WB Saunders;; 2000:112–133

    Google Scholar 

  46. Lai YY, Seigel JM. Medullary regions mediating atonia. J Neurosci 1988;8:4790–4796

    Google Scholar 

  47. Datta S, PattersonEH, Siwek DF. Endogenous and exogenous nitric oxide in the pedunculo-pontine tegmentum induces sleep. Synapse 1997;27:69–78

    Google Scholar 

  48. Lai YY, Seigel JM. Muscle tone suppression and stepping produced by stimulation of midbrain and rostral pontine reticular formation. J Neurosci 1990;10:2727–2738

    Google Scholar 

  49. Lai YY, Seigel JM. Ponto-medullary glutamate receptors mediating locomotion and muscle tone suppression. J Neurosci 1991;11:2931–2937

    Google Scholar 

  50. Prast H, Tran MH, FischerH, Philippu A. Nitric oxide induced release of acetycholine in the nucleus accumbens: role of cyclic GMP, glutamate and GABA. J Neurochem 1998;71:266–273

    Google Scholar 

  51. Kimura T, Yu JG, Edvinsson L, LeeTJF. Cholinergic nitric oxide innervation in cerebral arteries of the cat. Brain Res 1997;773:117–124

    Google Scholar 

  52. Bach-y-Rita P. Nonsynaptic diffusion neurotransmission (NDN) in the brain. Neurochem Int 1993;23:297–318

    Google Scholar 

  53. Liu X, Miller MJ, Joshi MS, Sadowska-Krowicka H, Clark DA, Lancaster JrJR. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem 1998;273:18709–18713

    Google Scholar 

  54. Krueger JM, Obal Jr F, Fang J, Kubota T, Taishi P. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci 2001;933:211–221

    Google Scholar 

  55. Sippel JM, Giraud GD, Holden WE. Nasal administration of the nitric oxide synthase inhibitor L-NAME induces daytime somnolence. Sleep 1999;22:786–788

    Google Scholar 

  56. Cespuglio R, Burlet S, Marinesco S, Robert F, Jouvet M. Volumetric detection of cerebral NO in rats. Variations of the signal throughout the sleep-wakefulness cycle. C R Acad Sci III 1996;319:191–200

    Google Scholar 

  57. Kato M, Roberts, Thomson P, et al. Impairment of endothelium dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607–2610

    Google Scholar 

  58. Shepard JrJW, Garrison MW, Grither DA, et al. Relationship of ventricular ectopy to nocturnal oxygen desaturation in patients with chronic obstructive pulmonary disease. Am J Med 1995;78:28–34

    Google Scholar 

  59. Butkov N. Atlas of Clinical PolysomngraphySynapse Media Inc; 1996

  60. Haight JSJ, Qian W. Hypoxia depresses nitric oxide output in the human nasal airway. Laryngoscope 2000;110:429–433

    Google Scholar 

  61. Duchna HW, Guilleminault C, StoohsRA, et al. Obstructive sleep apnea syndrome: a cardiovascular risk factor?. Zschr Kardiol 2001;90:568–575

    Google Scholar 

  62. Ip MS, Lam B, ChanLY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care 2000;162:2166–2171

    Google Scholar 

  63. Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000;55:1046–1051

    Article  CAS  PubMed  Google Scholar 

  64. McQuillan LP, Leung GK, Marsden PA, Kostyk SK, Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and post-transcriptional mechanisms. Am J Physiol 1994;267(5 Pt 2):H1921–1927

    Google Scholar 

  65. Carlson J, Hedner J, Pettersson A. Increased plasma concentration of ADMA, a naturally occurring nitric oxide synthesis inhibitor, in OSA patients. Am J Respir Crit Care 1997;155:A869–A869

    Google Scholar 

  66. Schulz R, Seeger W, Grimminger F. Serum nitrite/nitrate levels in obstructive sleep apnea [letter]. Am J Respir Crit Care 2000;164:1997–1998

    Google Scholar 

  67. Lavery CE, Mittleman MA, Cohen MC, et al. No uniform nighttime distribution of acute cardiac events. A possible effect of sleep states. Circulation 1997;96:3321–3327

    Google Scholar 

  68. Muller JG, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733–743

    CAS  PubMed  Google Scholar 

  69. Rossi GB, Seccia TM, Nussdorfer GG. Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. Int Rev Cytol 2001;209:241–272

    Google Scholar 

  70. Gewaltig MT, Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 2002;55:250–260

    Google Scholar 

  71. Hung J, WithfordEG, Parsons RW, Hillman DR. Association of sleep apnea with myocardial infarction in men. Lancet 1990;336:261–264

    Google Scholar 

  72. Koskenvuo M, Kaprio J, Telakivi T, et al. Snoring as a risk factor for ischemic heart disease and stroke in men. Br Med J 1987;294:16–19

    Google Scholar 

  73. Ross R. Mechanisms of disease—atheroslerosis—an inflammatory disease. N Engl J Med 1999;340:115–126

    Article  CAS  PubMed  Google Scholar 

  74. Schwartz SM. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 1997;99:2814–2817

    Google Scholar 

  75. Scott-Burden T, VanhouttePM. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation 1993;87 (suppl 5):S51–S55

    Google Scholar 

  76. Nakaki T, Nakayama M, Kato R. Inhibition of nitric oxide and nitric oxide producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol Mol Pharmacol 1990;189:347–353

    Google Scholar 

  77. Bolli R. Cardioprotective function of inducible nitric oxide synthesis and role of nitric oxide in myocardial ischaemia and preconditioning: an overview of a decade research. J Mol Cell Cardiol 2001;33:1897–1918

    Google Scholar 

  78. Brooks D, HornerRL, Kozar LF, et al. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997;99:106–109

    Google Scholar 

  79. Brooks D, HornerRL, Kimoff LF, et al. Effect of obstructive sleep apnea versus sleep fragmentation on responses to airway occlusion. Am J Respir Crit Care Med 1997;155:1609–1617

    Google Scholar 

  80. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997;157:1746–1752

    Google Scholar 

  81. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. Br Med J 2000;320:479–482

    Google Scholar 

  82. Huang PL, Huang ZH, Mashimo H, et al. Hypertension in mice lacking the egene for endothelial nitric oxide synthase. Nature 1995;377:239–242

    Google Scholar 

  83. Kunsch C, MedfordRM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753–766

    CAS  PubMed  Google Scholar 

  84. Kojda G, HarrisonDG. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999;43:562–571

    Google Scholar 

  85. Massberg S, Sausbier M, Klatt P, et al. Increased adhesion and aggregation of platelets lacking cyclic guanosine 3’-5’-monophosphate kinase I. J Exp Med 1999;189:1255–1263

    Google Scholar 

  86. Kubes P, Suzuki M, GrangerDN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991;88:4651–4655

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, St. Michael’s Hospital, University of Toronto, Toronto, Canada

    James S. J. Haight M.D., Ph.D., F.R.C.S.(C.)

  2. OptiNose AS, Løkkaskogen 18c, 0773, Oslo, Norway

    Per Gisle Djupesland M.D., Ph.D.

Authors
  1. James S. J. Haight M.D., Ph.D., F.R.C.S.(C.)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Per Gisle Djupesland M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haight, J.S.J., Djupesland, P.G. Nitric Oxide (NO) and Obstructive Sleep Apnea (OSA). Sleep Breath 7, 53–61 (2003). https://doi.org/10.1007/s11325-003-0053-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-003-0053-4

Keywords

Search

Navigation